Company Analysis
Sign in

Cybin Inc. (HELP)

Nasdaq: HELP · Pharmaceutical Preparations · Toronto, ON · filing with the SEC since 2020
Full chart Alerts Compare
Grade5.3
◀ Past 5.0● Present 5.2▶ Future 5.6
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2022, as filed
RevenueC$0.00-100.0%
Net income-C$67.6M-109.9%
Earnings per shareC$-15.20-25.0%
Operating cash flow-C$45.2M-137.6%
CashC$53.6M-16.2%
Debtn/a
Shareholders’ equityC$76.2M-11.6%
Shares, diluted4,402,296+67.3%
Return on equity-47.7%
The recordfrom its filings
Filings in 202693
Newest filingNov 12 · SCHEDULE 13G/A
Annual reportJun 29, 2026
Quarterly reportn/a
Next report due40-F by Jul 29
Insider sales, 12 months$0.00
Insider buys, 12 months$9.7M
Patents grantedn/a
Filer category<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
2122232425
As filed, in CAD. Nothing here is a forecast.

News

An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton HELP · research, not advice